Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now     
Bio B2BNang Kuang Pharmaceutical Co., Ltd. 〉Ibandraonte PFS Inj.

Ibandraonte PFS Inj.

Ibandraonte PFS Inj.

Ibandronate is indicated for the treatment and prevention of osteoporosis in post-menopausal women. U.S. Food and Drug Administration (FDA) approved Ibandronate as a daily treatment for post-menopausal osteoporosis.Every participant also received daily oral doses of calcium and 400IUs of vitamin D. At the study's conclusion, both doses significantly reduced the occurrence risk of new vertebral fractures by 50–52 percent when compared to the effects of the placebo drug.

Request for Collaboration
People who like this also like
  • ANTISURASE B-96ANTISURASE B-96
  • HEPAVASE MA-96 (TMB)HEPAVASE MA-96 (TMB)
  • Zulitor Tablets 4mgZulitor Tablets 4mg
  • Pitator Tablets 2mgPitator Tablets 2mg
  • CRC ProtectCRC Protect
  • 3A Hip Nail System3A Hip Nail System
  • NanoQ Coenzyme Q10 ProductsNanoQ Coenzyme Q10 Products
  • Anscare ChitoClot PadAnscare ChitoClot Pad
  • SURASE B-96 (TMB)SURASE B-96 (TMB)
  • DNA Repair Gene TestingDNA Repair Gene Testing